(MedPage Today) — A novel drug for systemic lupus erythematosus (SLE) first developed in China, and approved there since 2021, did well enough in a new placebo-controlled phase III trial that approval in Western countries seems possible.
Called…
Source link : https://www.medpagetoday.com/rheumatology/lupus/117957
Author :
Publish date : 2025-10-15 21:00:00
Copyright for syndicated content belongs to the linked Source.
